ARTL · Artelo Biosciences Inc
United States · RS rating 37 · As of 2026-11-03
| Price | 2.40 USD |
|---|---|
| 1-day change | +10.6% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 11 / 98 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 29 / 18 / 55 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +77.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +77.2% |
| Market cap (USD) | $3.7M |